Literature DB >> 12560353

Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry.

Pål I Holm1, Per Magne Ueland, Gry Kvalheim, Ernst A Lien.   

Abstract

BACKGROUND: The quaternary ammonium compounds, choline and betaine, and dimethylglycine (DMG) reside along a metabolic pathway linked to the synthesis of neurotransmitters and membrane phospholipids and to homocysteine remethylation and, therefore, folate status. Lack of a convenient, high-throughput method for the determination of these compounds has prevented population-based studies of their possible associations with lifestyle, nutrition, and chronic diseases.
METHODS: Serum or plasma samples were deproteinized by mixing with three volumes of acetonitrile that contained d(9)-choline and d(9)-betaine as internal standards. We used a normal-phase silica column for the separation of choline (retention time, 2.8 min), betaine (1.3 min), DMG (1.15 min), and internal standards, which were detected as positive ions by tandem mass spectroscopy in the multiple-reaction monitoring mode, using the molecular transitions m/z 104-->60 (choline), m/z 113-->69 (d(9)-choline), m/z 118-->59 (betaine), m/z 127-->68 (d(9)-betaine), and m/z 104-->58 (DMG).
RESULTS: For all three metabolites, the assay was linear in the range 0.4-400 micromol/L, and the lower limit of the detection (signal-to-noise ratio = 5) was < or =0.3 micromol/L. The within- and between-day imprecision (CVs) was 2.1-7.2% and 3.5-8.8%, respectively. The analytical recovery was 87-105%. The fasting plasma concentrations (median, 25th-75th percentiles) were 8.0 (7.0-9.3) micromol/L for choline, 31.7 (27.0-41.1) micromol/L for betaine, and 1.66 (1.30-2.02) micromol/L for DMG in 60 healthy blood donors. In individuals who had eaten a light breakfast, plasma concentrations of all three metabolites were significantly (25-30%) higher than in fasting individuals.
CONCLUSION: This is the first method for the combined measurement of choline, betaine, and DMG in human plasma or serum. The assay is characterized by simple sample preparation, no derivatization, high throughput, imprecision (CV) <10%, detection limits below the values seen in volunteers, and the high specificity provided by tandem mass spectroscopy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560353     DOI: 10.1373/49.2.286

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  81 in total

1.  Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine.

Authors:  Elango Kathirvel; Kengathevy Morgan; Ganesh Nandgiri; Brian C Sandoval; Marie A Caudill; Teodoro Bottiglieri; Samuel W French; Timothy R Morgan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

2.  Higher serum concentrations of betaine rather than choline is associated with better profiles of DXA-derived body fat and fat distribution in Chinese adults.

Authors:  Y-M Chen; Y Liu; Y-H Liu; X Wang; K Guan; H-L Zhu
Journal:  Int J Obes (Lond)       Date:  2014-08-25       Impact factor: 5.095

3.  Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia.

Authors:  Roy M Nilsen; Anne-Lise Bjørke-Monsen; Oivind Midttun; Ottar Nygård; Eva R Pedersen; Arve Ulvik; Per Magnus; Håkon K Gjessing; Stein Emil Vollset; Per Magne Ueland
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

4.  Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring.

Authors:  M Camille Hoffman; Sharon K Hunter; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman
Journal:  Psychol Med       Date:  2019-07-31       Impact factor: 7.723

5.  Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults.

Authors:  Megan N Hall; Caitlin G Howe; Xinhua Liu; Marie A Caudill; Olga Malysheva; Vesna Ilievski; Angela M Lomax-Luu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad N Uddin; Tariqul Islam; Joseph H Graziano; Mary V Gamble
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

6.  Choline supplementation alters some amino acid concentrations with no change in homocysteine in children with cystic fibrosis and pancreatic insufficiency.

Authors:  Belal Alshaikh; Joan I Schall; Asim Maqbool; Maria Mascarenhas; Michael J Bennett; Virginia A Stallings
Journal:  Nutr Res       Date:  2015-12-29       Impact factor: 3.315

7.  The altered human serum metabolome induced by a marathon.

Authors:  Zinandré Stander; Laneke Luies; Lodewyk J Mienie; Karen M Keane; Glyn Howatson; Tom Clifford; Emma J Stevenson; Du Toit Loots
Journal:  Metabolomics       Date:  2018-11-03       Impact factor: 4.290

8.  Renal function is associated with indicators of arsenic methylation capacity in Bangladeshi adults.

Authors:  Brandilyn A Peters; Megan N Hall; Xinhua Liu; Vesna Slavkovich; Vesna Ilievski; Shafiul Alam; Abu B Siddique; Tariqul Islam; Joseph H Graziano; Mary V Gamble
Journal:  Environ Res       Date:  2015-10-19       Impact factor: 6.498

9.  Associations between Plasma Choline Metabolites and Genetic Polymorphisms in One-Carbon Metabolism in Postmenopausal Women: The Women's Health Initiative Observational Study.

Authors:  Mmadili N Ilozumba; Ting-Yuan D Cheng; Marian L Neuhouser; Joshua W Miller; Shirley A A Beresford; David J Duggan; Adetunji T Toriola; Xiaoling Song; Yingye Zheng; Lynn B Bailey; Aladdin H Shadyab; Simin Liu; Olga Malysheva; Marie A Caudill; Cornelia M Ulrich
Journal:  J Nutr       Date:  2020-11-19       Impact factor: 4.798

10.  Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency.

Authors:  Renata H Bahous; Marta Cosín-Tomás; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Ming-Kai Ho; Mercè Pallàs; Perla Kaliman; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.